RECURSION PHARMACEUTICALS, INC. - CL A (RXRX)

Q4 2022 13F Holders as of 12/31/2022

Type / Class
Equity / CL A
Number of holders
142
Total Shares
124M
Shares change
+18M
Total reported value, excl. options
$954M
Value change
+$135M
Put/Call ratio
0.45
Number of buys
82
Number of sells
-42
Price
$7.71
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.